Evidence map›Paper›PMID 23076260›Full record

ArticleHistochemistry and cell biology2013

Choosing the right antibody for resistin-like molecule (RELM/FIZZ) family members.

Chunling Fan, Brian A Johns, Qingning Su, Irina A Kolosova, Roger A Johns

Abstract read
In one paragraph

Article in Histochemistry and cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Resistin family proteins in pulmonary diseases.American journal of physiology. Lung cellular and molecular physiology · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Resistin-Like Molecule α in Allergen-Induced Pulmonary Vascular Remodeling.American journal of respiratory cell and molecular biology · 2015
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chunling FanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Brian A Johns
Qingning Su
Irina A Kolosova
Roger A Johns

Funding

Targeting resitin and RELM-beta to treat pulmonary hypertensionUH3HL123827 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI JOHNS, ROGER A · 2016 to 2018
$4.9M
Targeting resitin and RELM-beta to treat pulmonary hypertensionUH2HL123827 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI JOHNS, ROGER A · 2014 to 2015
$3.1M
REGULATION OF NO SIGNALING IN PULMONARY VASCULATURER01HL039706 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI JOHNS, ROGER A · 1993 to 2006
$2.4M
Targeting resitin and RELM-beta to treat pulmonary hypertensionP50HL107182 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI JOHNS, ROGER A · 2011 to 2012
$983k
NHLBI NIH HHS P50 HL107182NHLBI NIH HHS P50HL107182NHLBI NIH HHS R01 HL039706NHLBI NIH HHS UH2 HL123827NHLBI NIH HHS UH3 HL123827PHS HHS P50084946
6 · The paper itself

Abstract

The family of resistin-like molecules (RELM), also known as found in inflammatory zone (FIZZ), consists of four members in mouse (RELMα/FIZZ1/HIMF, RELMβ/FIZZ2, Resistin/FIZZ3, and RELMγ/FIZZ4) and two members in human (resistin and RELMβ). The importance of these proteins in many aspects of physiology and pathophysiology, especially inflammatory processes, is rapidly evolving in the literature, and many investigators are beginning to work in this field. Most published studies focus on only one isoform, do not evaluate other isoforms that might be present, and have not tested for the specificity of the antibody used. Because RELM isoforms have high sequence and structural similarity and both distinct and overlapping functions, it is important to use a specific antibody to distinguish each isoform in the study. We constructed and established HEK 293 cell lines that constitutively express each isoform. Using these cell lines, we determined the specificity of antibodies (both commercially available and laboratory-made) to each isoform by Western blot and immunofluorescence. Some of the antibodies showed specificity in Western blotting but were not applicable in immunofluorescence. Others showed cross reactivity in Western blot assays. Our results indicate that RELM antibody specificity should be taken into account when using them in research and interpreting data obtained with them.

Indexed as

AnimalsAntibodiesAntibody SpecificityCell LineHEK293 CellsHormones, EctopicHumansIntercellular Signaling Peptides and ProteinsMiceProtein IsoformsRecombinant Fusion ProteinsResistinAntibodiesHormones, EctopicIntercellular Signaling Peptides and ProteinsProtein IsoformsRecombinant Fusion ProteinsResistinresistin-like gamma, mouseRetnla protein, mouseRETNLB protein, humanRetnlb protein, mouse

Identifiers

PMID23076260
PMCPMC6822273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.